Close menu




December 7th, 2020 | 09:39 CET

Nordex, Osino Resources, home24 - good news far from being processed in the price

  • Investments
Photo credits: pixabay.com

Information is not always wholly and immediately reflected in the price of securities. Especially for companies outside the large caps, this information processing takes longer, which often opens up suitable trading and investment opportunities for investors. Who will win the race?

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: CA68828L1004 , DE000A0D6554 , DE000A14KEB5

Table of contents:


    Nordex - oversubscribed capital increase

    At the beginning of December, Nordex SE raised around EUR 200 million from international institutional investors in a capital increase. According to the Company, the transaction, in which 10.7 million share certificates were offered at a price of EUR 18.90, was substantially oversubscribed.

    The North German wind turbine manufacturer intends to use the inflow of funds to continue growing, implement strategic measures and strengthen its balance sheet. At the end of September, the Group had orders in hand in the "Projects" and "Service" segments worth EUR 7.9 billion. As these orders are increasingly processed using the latest product platform, higher margins can be realized in the future.

    The fresh capital strengthens the equity base and enables accelerated growth. However, consolidation often occurs shortly after a capital increase due to the dilution effect. After a short break, the Company, which is currently valued at a market capitalization of around EUR 2.2 billion, should be able to grow further.

    Osino Resources - good news with great potential

    Osino Resources Corp. is a Canadian gold exploration Company focused on the acquisition and development of gold projects in Namibia. Namibia is mining-friendly and considered one of the most stable jurisdictions on the continent, both politically and socially. The Company holds a total of 23 exclusive prospecting licenses in the vicinity and along the mineralized zones of the producing gold mines Navachab (QKR Namibia) and Otjikoto (B2Gold Corp.). The management has extensive experience in the development of mine projects and their sale. The discovery of new mineral deposits is a catalyst for rising prices in the short term. In the medium term, it is the potential to sell projects or the whole Company.

    Osino owns an area of an impressive 6,577 square kilometres. This year the Company focused, among other things, on the definition and development of the new Twin Hills gold discovery. In mid-November, Osino reported good news, which in our opinion is not yet sufficiently reflected in the share price. Interpretation of drill results from the Both Clouds East and West sections within the Twin Hills Central Zone suggests that the length of the mineralization trend has doubled from 1,500 to 3,000 metres.

    The stock is quoted at CAD 1.25 and has a market capitalization of CAD 125 million. Given the vast land package and good news flow, the stock is favorably valued.

    home24 - a double opportunity for investors

    home24 is a leading pure-home & living e-commerce platform in continental Europe and Brazil. The Berlin-based Company employs more than 1,500 people worldwide and is active in seven European countries. home24 is present in Brazil under the brand "Mobly".

    Recently, the Company raised its targets for the current fiscal year due to an increase in incoming orders and higher profitability. Based on the strong performance of the share and a significantly increased liquidity, the Company, valued at just under EUR 500 million, will be included in the DAX on December 21.

    At the end of last week, home24 announced plans to initiate the process for an IPO of its Brazilian subsidiary. The IPO will take place in February 2021 at the earliest and will contribute to accelerating the growth of the Brazilian Company. Such "spin-offs" often give the shares of the parent company a good performance, but statistically speaking, the spin-off companies perform even better. And here lurks a double opportunity for investors.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read